Press archive
The 20 recent news
01/07/09, Research & Development Visanne® - new long-term treatment for endometriosis submitted for registration in Europe Berlin, January 7, 2009 – Bayer Schering Pharma AG, Germany, has submitted Visanne® for the treatment of endometriosis for registration to all Member States of the European Community. The Neth... more
12/08/08, Rivaroxaban/Xarelto Xarelto® Reduces Symptomatic VTE and Death Following Knee or Hip Replacement Surgery by More Than 50% Compared to Enoxaparin in Pooled Analysis of RECORD Clinical Trial Program Pooled Analysis of RECORD1-4 Trials Confirms Significant Benefit in Clinical Outcomes for Patients Treated with Xarelto / RECORD4 Study Demonstrates Xarelto is the Only Oral Anticoagulant to Show Cli... more
12/04/08, Company Bayer expands men’s healthcare portfolio Licence agreement for innovative testosterone gel also covers emerging markets more
11/13/08, Company Bayer named best pharmaceutical and chemical company in Brazil Survey of 12,000 consumers more
11/13/08, Multiple sclerosis No equal access to Multiple Sclerosis treatment and care in Europe New findings presented by the European Multiple Sclerosis Platform at the European Parliament in Brussels / Bayer Schering Pharma presents new book for caregivers “Together we’ll make it&... more
11/10/08, Research & Development Bayer’s Xarelto® Shows Encouraging Results in Patients with Acute Coronary Syndrome Phase II Data Presented as Late-Breaker at American Heart Association Meeting / Phase III Study to be Initiated in December 2008 more
10/29/08, Company Bayer optimistic about future business trend Sales rise by 2.0 percent to EUR 7,948 million (Q3 2007: EUR 7,793 million) / HealthCare and CropScience improve earning power / MaterialScience earnings significantly lower / Group EBITDA before spe... more
10/16/08, Research & Development First estradiol-based oral contraceptive Qlaira® cleared for market launch in Europe A new oral contraceptive providing the same estrogen produced by the female body more
10/15/08, Women’s Healthcare Promoting health care and human rights in developing countries Results will help to achieve the Millennium Development Goals and be incorporated into the 2009 International Conference on Population and Development / Bayer Schering Pharma supports family planning... more
10/06/08, Research & Development Bayer Reports Progress in Clinical Program for Riociguat Positive Phase II Findings Reported at European Respiratory Society Meeting / Phase III Studies to Begin in 2008 more
10/01/08, Rivaroxaban/Xarelto Bayer’s Novel Anticoagulant Xarelto® now also Approved in the EU Bayer will start marketing the new oral, once-daily anticoagulant very soon / First-in-class product to demonstrate superior efficacy to current standard of care more
09/30/08, Research & Development Bayer starts new research cooperation in Asia Research collaboration with National University of Singapore signed / Further collaborations planned / Overall investment volume of 10 million Euro more
09/28/08, Research & Development VEGF Trap-Eye: New Data Confirm Successes in the Treatment of Age-related Macular Degeneration Statistically significant reduction in the size of the affected area of the retina demonstrated more
09/25/08, Bayer HealthCare Squeeze-out entered in the Commercial Register Squeeze-out of minority stockholders takes effect / Cash compensation of EUR 98.98 per share will be paid more
09/20/08, Multiple sclerosis Five year data confirm that early treatment with Betaferon® at first sign of disease can delay progression to MS BENEFIT is first and only prospectively planned study to show long lasting benefit of early treatment more
09/16/08, Stories Advances in Renal Cancer Journalists’ Award Europe announced Bayer HealthCare and Association of German Medical Journalists (VDMJ) honor good medical reporting about Renal Cancer - Award is endowed with EUR 7,500 more
09/16/08, Research & Development Bayer HealthCare acquires German DIREVO Biotech AG A recognized leader in protein engineering / Expanding technological know-how in biologicals / Strengthening Bayer HealthCare’s commitment to develop innovative biologicals more
09/16/08, Research & Development Bayer’s Xarelto® Approved in Canada First approval for Bayer’s new oral, once-daily anticoagulant / Marketing to start immediately / First-in-class product to demonstrate superior efficacy to standard of care / Most studied oral,... more
09/15/08, Multiple sclerosis Bayer offers thinnest needle for its multiple sclerosis treatment Betaferon® in the U.S. Berlin, September 15, 2008 – Bayer will launch a 30-gauge needle for its multiple sclerosis treatment Betaferon® (interferon beta-1b) in the U.S. This will be the thinnest needle of any inject... more
09/10/08, Diagnostic Imaging Bayer Intensifies Research in Early Diagnosis of Alzheimer’s Disease Licensing agreement with Nagasaki University signed more
